Menopause, although a natural part of every woman's life, is very often accompanied by extremely uncomfortable symptoms, such as hot flashes, loss of libido, night sweats, sleep turbulence, significant mood changes, sometimes even clinical depression. As menopause progresses additional metabolic diseases may arise which can include vaginal dryness, urinary problems, bone loss (which can lead to osteoporosis) as well as other significant health issues including cardiovascular diseases.
Femarelle, is a safe and effective treatment for the management of both menopausal symptoms and bone loss. Femarelle's uniqueness lies in that it is a Selective Estrogen Receptor Modulator- (a SERM.) The selectivity in the estrogen receptor provides both menopausal symptoms relief and bone health, without affecting the sensitive tissues in the breast and uterus.
The scientific activity surrounding Femarelle has been published in major scientific and medical journals around the world and has received international recognition and acceptance by the medical community as a whole, both in their practices and in leading medical conventions.
Three out of four women report relief and alleviation of hot flashes in 76%, relief of joint & muscle pain in 70% and relief of headaches in 68% (the main symptoms associated with the menopause transition). Furthermore, the effect of Femarelle on the bones, exhibited a statistically significant increase of BMD after one year (12 months) of treatment. Most importantly, these clinical results were achieved without disturbing the hormonal blood profile and without leading to any change in endometrial thickness or other changes in the uterus. A study of its mechanism of action on BMD in human bone cultures showed that Femarelle exhibits unique bone-forming properties by increasing bone formation through osteoblast activity. Even further, Femerelle had no effect on breast cancer tissue formation in human breast cancer tissue culture studies.
The unique combination of coumestans and lignans in Femarelle provides an innovative and effective solution to menopausal symptoms. The selective mechanism of action of Femarelle allows it to act as an agonist on the estrogen receptors and thus exert a satisfactory effect on menopausal symptoms and BMD while having an aggressive effect on the estrogen receptors in the breast and in the uterus, without negative side effects or the risk of health issues down the line.
Relief is often felt within the first month of treatment, (in three out of four women) which is very encouraging to those who's lives are effected daily by the discomfort of bodily changes due to menopause.
No comments:
Post a Comment